organization · Reporting owner
Health Sciences Holdings, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Immunovant, Inc.
Report date December 18, 2019 · Filed December 20, 2019
Section 16 reporting ended · disclosed 2019-12-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrants to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 0 |
Reported balance
After 2019-12-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-12-18 · Other · Disposed 10,000,000 · Balance 0 F1: The warrants were cancelled in connection with the business combination, consummated on December 18, 2019, by and between Health Sciences Acquisitions Corporation and Immunovant Sciences, Ltd. F2: The warrants become exercisable on May 9, 2020. F3: The warrants expire on December 18, 2024, or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. |
Filing footnotes · ownership attribution and instrument terms
F1: The warrants were cancelled in connection with the business combination, consummated on December 18, 2019, by and between Health Sciences Acquisitions Corporation and Immunovant Sciences, Ltd.
F2: The warrants become exercisable on May 9, 2020.
F3: The warrants expire on December 18, 2024, or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2019 Filed Dec 20, 2019 16:56 UTC | Immunovant, Inc. IMVT · Entity 3632 | OtherWarrants to purchase Common Stock · Derivative | 10,000,000 | $0.50 Strike: $11.50 | $5,000,000.00 |
DisclosureSEC source: 0001213900-19-026634 · ownership.xml · derivative · entry 1 Health Sciences Holdings, LLC · CIK 0001776357 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000,000 shares Expires not disclosed F1 · kind: The warrants were cancelled in connection with the business combination, consummated on December 18, 2019, by and between Health Sciences Acquisitions Corporation and Immunovant Sciences, Ltd. F2 · derivative.exercise_date: The warrants become exercisable on May 9, 2020. F3 · derivative.expiration_date: The warrants expire on December 18, 2024, or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document |
| May 14, 2019 Filed May 15, 2019 15:33 UTC | Immunovant, Inc. HSACU · Entity 3632 | PurchaseWarrants to purchase Common Stock · Derivative | 10,000,000 | $0.50 Strike: $11.50 | $5,000,000.00 |
DisclosureSEC source: 0001615774-19-007862 · s118355_form4.xml · derivative · entry 1 Health Sciences Holdings, LLC · CIK 0001776357 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000,000 Underlying: Common Stock · 5,000,000 shares Expires not disclosed F1 · derivative.exercise_date: The warrants become exercisable on the later of (i) 30 days from the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering. F2 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.